Of those remaining, the largest number of calls with predicted expansions were the ones in DMPK (myotonic dystrophy), GLS (global developmental delay, progressive ataxia and elevated glutamine) and HTT (Huntington disease). This evidence concerns the gene GLS and juvenile Huntington disease.